Abbreviations: CIN, cervical intraepithelial neoplasia; HPV, human papilloma virus; p16, p16INK4a; MCM2, minichromosome maintenance protein 2; TPO2A, DNA topoisomerase IIHChybridcapture II: LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion. Key words: Cervical cancer; p16; ProEx C; HPV; carcinogenesis.Running title: ProEx C and p16 expressions in CIN
SummaryThe aim of this study was to reveal whether three biomarkers (p16, ProEx C, and HPV DNA) are useful in the diagnosis of cervical intraepithelial neoplasia and whether they could predict disease progression of cervical intraepithelial neoplasia-1.We analyzed 252 cervical specimens: non-dysplastic mucosa (n=9), cervical intraepithelial neoplasia (n=229), and squamous cell carcinoma (n=14). Immunostaining for p16 and ProEx C, and the hybridcapture II assay for HPV DNA were performed.Expression of p16 and staining for ProEx C were significantly higher in intraepithelial neoplasia-2/3 (96% to 100%) than in non-dysplastic mucosa (11%) or intraepithelial neoplasia-1 (40% to 53%). HPV DNA was detected in 69% of intraepithelial neoplasia-1, 95% of intraepithelial neoplasia-2, and 100% of intraepithelial neoplasia-3.Of 99 patients with intraepithelial neoplasia-1 for whom follow-up data was available, 62 (73%) showed spontaneous regression, 17 (20%) demonstrated persistent low-grade lesion, and 7 (7%) progressed to intraepithelial neoplasia-2/3. Expressions of p16 and staining with ProEx C were significantly higher in the progression group than in the regression group. Testing for p16 and ProEx C were sensitive (86%) and moderately specific (60% and 61%, respectively) in predicting the progression of cervical intraepithelial neoplasia-1. HPV DNA testing was highly sensitive (100%) but less specific (37%). In conclusion, this study revealed that p16 and ProEx C are useful biomarkers for the diagnosis of cervical intraepithelial neoplasia, and have potential as predictors of progression of low-grade lesions.